Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Tumour Burden Influence on Individual Rituximab Exposure and Response: Pharmacokinetic - Pharmacodynamic Approach by Using a Syngenic Bioluminescent Murine Model.

David Daydé, David Ternant, Stéphanie Lerondel, Hervé Watier, Alain Le Pape, Pierre Bardos, Gilles Paintaud, Guillaume Cartron, (Intr. by Jean-Francois Rossi)

Blood (2007) 110 (11): 2347.

https://doi.org/10.1182/blood.V110.11.2347.2347

Published: 2007

Journal Articles

Quantitative Bioluminescent Method Appropriate for Bimodality Analysis To Improve and Follow a Syngenic Murine Model of B-Cell Lymphoma Expressing Human CD20.

David Daydé, Florence Dommange, Stéphanie Lerondel, Josée Golay, Alain Le Pape, Gilles Paintaud, Pierre Bardos, Hervé Watier, Guillaume Cartron

Blood (2007) 110 (11): 1400.

https://doi.org/10.1182/blood.V110.11.1400.1400

Published: 2007

Journal Articles

Dose-response relationship and pharmacogenetics of anti-RhD monoclonal antibodies

David Ternant, Marc Ohresser, Cécile Thomas, Guillaume Cartron, Hervé Watier, Gilles Paintaud

Blood (2005) 106 (4): 1503–1505.

https://doi.org/10.1182/blood-2005-02-0798

Published: 2005

Journal Articles

The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes

Yves Gruel, Claire Pouplard, Dominique Lasne, Charlotte Magdelaine-Beuzelin, Chloé Charroing, Hervé Watier

Blood (2004) 104 (9): 2791–2793.

https://doi.org/10.1182/blood-2004-01-0058

Published: 2004

Journal Articles

From the bench to the bedside: ways to improve rituximab efficacy

Guillaume Cartron, Hervé Watier, Josée Golay, Philippe Solal-Celigny

Blood (2004) 104 (9): 2635–2642.

https://doi.org/10.1182/blood-2004-03-1110

Published: 2004

Journal Articles

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Guillaume Cartron, Laurent Dacheux, Gilles Salles, Philippe Solal-Celigny, Pierre Bardos, Philippe Colombat, Hervé Watier

Blood (2002) 99 (3): 754–758.

https://doi.org/10.1182/blood.V99.3.754

Published: 2002

NARROW

Tumour Burden Influence on Individual Rituximab Exposure and Response: Pharmacokinetic - Pharmacodynamic Approach by Using a Syngenic Bioluminescent Murine Model.

Quantitative Bioluminescent Method Appropriate for Bimodality Analysis To Improve and Follow a Syngenic Murine Model of B-Cell Lymphoma Expressing Human CD20.

Dose-response relationship and pharmacogenetics of anti-RhD monoclonal antibodies

The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes

From the bench to the bedside: ways to improve rituximab efficacy

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Email alerts

ASH Publications

American Society of Hematology

Tumour Burden Influence on Individual Rituximab Exposure and Response: Pharmacokinetic - Pharmacodynamic Approach by Using a Syngenic Bioluminescent Murine Model.

Quantitative Bioluminescent Method Appropriate for Bimodality Analysis To Improve and Follow a Syngenic Murine Model of B-Cell Lymphoma Expressing Human CD20.

Dose-response relationship and pharmacogenetics of anti-RhD monoclonal antibodies

The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes

From the bench to the bedside: ways to improve rituximab efficacy

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only